Abstract:Abstract Background The etiology of Alzheimer’s disease (AD) is currently unknown, but several risk factors have been associated with AD including infectious agents. The central nervous system (CNS) is continuously monitored by immune cells, many of which circulate through the cerebrospinal fluid and the meninges. Meningeal immune cells respond to CNS‐intrinsic perturbations, such as neuroinflammation or neurodegeneration as well as to CNS‐extrinsic challenges, such as systemic infection. The goal of the study is to analyze the profile of meningeal immune cells and T cell clonality in AD in comparison with other neurodegenerative diseases. Method We used single‐cell RNA and T‐cell receptor (TCR) sequencing to characterize CD45+ immune cells from fresh leptomeninges from AD, Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). Result We identified multiple myeloid and lymphoid clusters in all neurodegenerative samples including meningeal macrophages expressing CD14 and C1QA and the resident meningeal macrophage marker LYVE‐1. Lymphoid populations represented the majority of total cells and were composed of both CD8+ effector memory T‐cells and a mixed population of NK cells and NK‐like T‐cells. Ligand/receptor network analyses identified several significant intercellular interactions including osteopontin signaling between meningeal macrophages and both clonally expanded cytotoxic CD8 T and NK/NK‐like T‐cells. TCR sequence analysis revealed up to 500 unique TCR clonotypes in each sample, many of which were hyperexpanded with 25‐50% of the TCR repertoire being occupied by the top 20 clonotypes and some of which had high TCRa chain sequence homology to EBV‐specific TCRs. Conclusion We provide evidence for disrupted myeloid homeostasis and broad T‐cell clonal expansion in the leptomeninges of AD patients. Network analyses suggest that meningeal macrophages in neurodegeneration may promote long‐term clonally expanded T‐cell survival through osteopontin signaling. These data recapitulate findings across several animal studies and will be useful in developing immunomodulatory interventions to treat neurodegeneration.

T cell–microglia signaling exacerbates neuropathology in an Alzheimer’s disease model

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

Infiltrating CD8+ T cells exacerbate Alzheimer’s disease pathology in a 3D human neuroimmune axis model

Infiltrating CD8+ T cells exacerbate Alzheimer's disease pathology in a 3D human neuroimmune axis model

The neuroimmune axis of Alzheimer's disease

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Clonal CD8 T Cells Accumulate in the Leptomeninges and Communicate with Microglia in Human Neurodegeneration

Cell States and Interactions of CD8 T Cells and Disease-Enriched Microglia in Human Brains with Alzheimer's Disease

Peripheral T cells derived from Alzheimer's disease patients overexpress CXCR2 contributing to its transendothelial migration, which is microglial TNF-α-dependent

CXCR6 orchestrates brain CD8 + T cell residency and limits mouse Alzheimer's disease pathology

CXCR6 Orchestrates Brain CD8+ T Cell Residency and Limits Mouse Alzheimer’s Disease Pathology

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer’s disease

Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease

T cell-mediated microglial activation triggers myelin pathology in a mouse model of amyloidosis

Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States

CNS Immune Surveillance in Alzheimer’s Disease

Clonal CD8 T cells in the leptomeninges are locally controlled and influence microglia in human neurodegeneration

CD8 + T cells exacerbate AD-like symptoms in mouse model of amyloidosis

Microglia drive APOE-dependent neurodegeneration in a tauopathy mouse model

The adaptive immune system restrains Alzheimer’s disease pathogenesis by modulating microglial function

T cell infiltration mediates neurodegeneration and cognitive decline in Alzheimer's disease